BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 40233)

  • 21. Neonatal mouse model: review of methods and results.
    McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
    Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Threshold levels in toxicology: significance of inactivation mechanisms.
    Greim H; Andrae U; Göggelmann W; Hesse S; Schwarz LR; Summer KH
    Adv Exp Med Biol; 1981; 136 Pt B():1389-98. PubMed ID: 7046388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents.
    Huff J; Cirvello J; Haseman J; Bucher J
    Environ Health Perspect; 1991 Jun; 93():247-70. PubMed ID: 1773796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural carcinogens and dioxin.
    Ames BN
    Sci Total Environ; 1991 May; 104(1-2):159-66. PubMed ID: 1871587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE; Cline JC; Thompson CZ
    Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemicals classified by IARC: their potency in tests for carcinogenicity in rodents and their genotoxicity and acute toxicity.
    McGregor DB
    IARC Sci Publ; 1992; (116):323-52. PubMed ID: 1428089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relevance of short-term carcinogenicity tests to the study of the carcinogenic potential of urban air.
    Harnden DG
    Environ Health Perspect; 1978 Feb; 22():67-70. PubMed ID: 648491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of rodent carcinogens by an expert system.
    Rosenkranz HS; Klopman G
    Prog Clin Biol Res; 1990; 340B():23-48. PubMed ID: 2203007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The carcinogenicity of anticancer drugs: a hazard in man.
    Harris CC
    Cancer; 1976 Feb; 37(2 Suppl):1014-23. PubMed ID: 766951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased attachment of nucleic acids to eukaryotic and prokaryotic cells induced by chemical and physical carcinogens and mutagens.
    Kubinski H; Morin NR; Zeldin PE
    Cancer Res; 1976 Sep; 36(9 pt.1):3025-33. PubMed ID: 975072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term tests for mutagenesis and carcinogenesis in drug toxicology: how to test and when to test is the question.
    De La Iglesia FA; Lake RS; Fitzgerald JE
    Drug Metab Rev; 1980; 11(1):103-46. PubMed ID: 6448737
    [No Abstract]   [Full Text] [Related]  

  • 33. Rodent carcinogens: setting priorities.
    Gold LS; Slone TH; Stern BR; Manley NB; Ames BN
    Science; 1992 Oct; 258(5080):261-5. PubMed ID: 1411524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens.
    Yoshikawa K
    Environ Health Perspect; 1996 Jan; 104(1):40-6. PubMed ID: 8834860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinogenicity testing of antitumor agents.
    Hottendorf GH
    Toxicol Pathol; 1985; 13(3):192-9. PubMed ID: 4070930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of mutagenic impurities in carcinogens and noncarcinogens by high-pressure liquid chromatography and the Salmonella/microsome test.
    Donahue EV; McCann J; Ames BN
    Cancer Res; 1978 Feb; 38(2):431-8. PubMed ID: 340030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing of chemicals for carcinogenic activities and some problems related to the assessment of carcinogenic risks to men.
    Schramm T; Teichmann B
    Pol J Pharmacol Pharm; 1979; 31(6):639-45. PubMed ID: 550120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The contribution of experimental studies to risk assessment of carcinogenic agents in humans.
    Tomatis L; Bartsch H
    Exp Pathol; 1990; 40(4):251-66. PubMed ID: 2098272
    [No Abstract]   [Full Text] [Related]  

  • 39. The origin of human cancers.
    Cairns J
    Nature; 1981 Jan; 289(5796):353-7. PubMed ID: 6258076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of risk of cancer to man.
    Peto R
    Proc R Soc Lond B Biol Sci; 1979 Jul; 205(1158):111-20. PubMed ID: 40232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.